JTCS Click here to go to SJM website.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
James D. Luketich
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raja, S.
Right arrow Articles by Godfrey, T. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raja, S.
Right arrow Articles by Godfrey, T. E.
Related Collections
Right arrow Esophagus - cancer

J Thorac Cardiovasc Surg 2002;123:475-483
© 2002 The American Association for Thoracic Surgery


General Thoraic Surgery (GTS)

Rapid, quantitative reverse transcriptase-polymerase chain reaction: Application to intraoperative molecular detection of occult metastases in esophageal cancer

Siva Raja, BSa, James D. Luketich, MDa, Lori A. Kelly, BSa, William E. Gooding, MSb, Sydney D. Finkelstein, MDc, Tony E. Godfrey, PhDa

From the Departments of Surgery,a Biostatistics,b and Pathology,c University of Pittsburgh Medical Center, Pittsburgh, Pa.

Supported by National Institutes of Health National Cancer Institute research grant CA90665-01.

Received for publication May 5, 2001; revisions requested June 27, 2001; revisions received Aug 16, 2001; accepted for publication Aug 30, 2001. Address for reprints: Division of Thoracic Surgery, Suite C-800 Presbyterian University Hospital, 200 Lothrop St, Pittsburgh, PA 15213.

Objective:Our earlier data showed that quantitative reverse transcriptase-polymerase chain reaction can discriminate patients with node-negative cancer who are at high risk for recurrence. The objective of this study was to determine whether a new, more rapid quantitative reverse transcriptase-polymerase chain reaction assay could provide this information in a time frame suitable for intraoperative decision making.
Methods:We studied formalin-fixed, archived lymph nodes from 30 patients with histologically determined node-negative esophageal cancer with rapid quantitative reverse transcriptase-polymerase chain reaction to measure expression of carcinoembryonic antigen messenger RNA. We also performed rapid quantitative reverse transcriptase-polymerase chain reaction on 37 snap-frozen lymph nodes from 23 patients. Eleven of the 23 patients had benign esophageal disorders (negative control group). The other 12 had esophageal cancer, 6 with histologically determined positive lymph nodes and 6 with histologically determined negative lymph nodes.
Results:In the retrospective analysis of archival tissue from 30 patients with esophageal cancer with histologically determined negative lymph nodes, rapid quantitative reverse transcriptase-polymerase chain reaction predicted disease recurrence with a sensitivity and a specificity of 90% and 80%, respectively, and was comparable to conventional quantitative reverse transcriptase-polymerase chain reaction. In the frozen-tissue analysis rapid quantitative reverse transcriptase-polymerase chain reaction detected significantly higher levels of carcinoembryonic antigen expression in all 12 of the histologically determined positive lymph nodes than in the benign nodes. For 2 of these 12 nodes the intraoperative frozen-section analysis had negative histologic results, and N1 status was determined only on final pathologic examination. Rapid (intraoperative) quantitative reverse transcriptase-polymerase chain reaction discriminated both nodes as positive. Among the 14 histologically determined negative nodes, 1 of 3 nodes from 1 patient showed increased carcinoembryonic antigen according to rapid quantitative reverse transcriptase-polymerase chain reaction, and this patient had a clinical recurrence.
Conclusions:In our study we were able to rapidly discriminate patients with node negative-esophageal cancer who had a high risk of recurrence. In frozen tissues rapid quantitative reverse transcriptase-polymerase chain reaction correlated with final pathologic report for 11 of 12 patients. In the 1 discordant case, the quantitative reverse transcriptase-polymerase chain reaction result was positive and may have detected microscopically occult metastasis, because this patient did have disease recurrence. Rapid quantitative reverse transcriptase-polymerase chain reaction was more sensitive than intraoperative frozen sections for detecting metastatic disease. These data suggest that rapid quantitative reverse transcriptase-polymerase chain reaction may have a prognostic role and could guide intraoperative decisions.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
C. Nwogu, G. Fischer, D. Tan, M. Glinianski, D. Lamonica, and T. Demmy
Radioguided Detection of Lymph Node Metastasis in Non-Small Cell Lung Cancer
Ann. Thorac. Surg., November 1, 2006; 82(5): 1815 - 1820.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
L. Xi, W. Gooding, K. McCarty, T. E. Godfrey, and S. J. Hughes
Identification of mRNA markers for molecular staging of lymph nodes in colorectal cancer.
Clin. Chem., March 1, 2006; 52(3): 520 - 523.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Ito, Y. Minamiya, H. Kawai, S. Saito, H. Saito, K. Imai, and J.-i. Ogawa
Intraoperative detection of lymph node micrometastasis with flow cytometry in non-small cell lung cancer
J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 753 - 758.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Raja, J. Ching, L. Xi, S. J. Hughes, R. Chang, W. Wong, W. McMillan, W. E. Gooding, K. S. McCarty Jr, M. Chestney, et al.
Technology for Automated, Rapid, and Quantitative PCR or Reverse Transcription-PCR Clinical Testing
Clin. Chem., May 1, 2005; 51(5): 882 - 890.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. L. Ferris, L. Xi, S. Raja, J. L. Hunt, J. Wang, W. E. Gooding, L. Kelly, J. Ching, J. D. Luketich, and T. E. Godfrey
Molecular Staging of Cervical Lymph Nodes in Squamous Cell Carcinoma of the Head and Neck
Cancer Res., March 15, 2005; 65(6): 2147 - 2156.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
T. El-Hefnawy, S. Raja, L. Kelly, W. L. Bigbee, J. M. Kirkwood, J. D. Luketich, and T. E. Godfrey
Characterization of Amplifiable, Circulating RNA in Plasma and Its Potential as a Tool for Cancer Diagnostics
Clin. Chem., March 1, 2004; 50(3): 564 - 573.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
S. Nagatani, Y. Shimada, Z. Li, J. Kaganoi, T. Kan, M. Maeda, G. Watanabe, and M. Imamura
Validation of Intra-operative Detection of Paratracheal Lymph Node Metastasis Using Real-time RT-PCR Targeting Esophageal Squamous Cell Carcinoma
Jpn. J. Clin. Oncol., November 1, 2003; 33(11): 549 - 555.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Raja, T. El-Hefnawy, L. A. Kelly, M. L. Chestney, J. D. Luketich, and T. E. Godfrey
Temperature-controlled Primer Limit for Multiplexing of Rapid, Quantitative Reverse Transcription-PCR Assays: Application to Intraoperative Cancer Diagnostics
Clin. Chem., August 1, 2002; 48(8): 1329 - 1337.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 by The American Association for Thoracic Surgery.